glp 1 for chronic inflammation GLP-1 Drugs: Multiple Conditions Frontiers | GLP-1 receptor agonists

Ozempic and other GLP-1 receptor agonists have rapidly become some of the most talked-about medications in the management of type 2 diabetes and weight-relat...

Here's what clinicians should know.

Patients with multiple comorbidities, especially those with limited treatment options, are significantly more likely to initiate GLP1 therapy

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication

Discover essential guidance on Ozempic and sun exposure, including sun safety practices, recognising skin reactions, and when to seek medical advice whilst taking semaglutide for type 2 diabetes.

Multiple randomized controlled trials have found CoQ10 supplementation helps reduce statin-related muscle pain, weakness, and fatigue